| Literature DB >> 10087263 |
Abstract
Oriented cell growth requires the specification of a site for polarized growth and subsequent orientation of the cytoskeleton towards this site. During mating, haploid Saccharomyces cerevisiae cells orient their growth in response to a pheromone gradient overriding an internal landmark for polarized growth, the bud site. This response requires Cdc24p, Far1p, and a heterotrimeric G-protein. Here we show that a two- hybrid interaction between Cdc24p and Gbeta requires Far1p but not pheromone-dependent MAP-kinase signaling, indicating Far1p has a role in regulating the association of Cdc24p and Gbeta. Binding experiments demonstrate that Cdc24p, Far1p, and Gbeta form a complex in which pairwise interactions can occur in the absence of the third protein. Cdc24p localizes to sites of polarized growth suggesting that this complex is localized. In the absence of CDC24-FAR1-mediated chemotropism, a bud site selection protein, Bud1p/Rsr1p, is essential for morphological changes in response to pheromone. These results suggest that formation of a Cdc24p-Far1p-Gbetagamma complex functions as a landmark for orientation of the cytoskeleton during growth towards an external signal.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10087263 PMCID: PMC2150586 DOI: 10.1083/jcb.144.6.1187
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 10.539
Yeast Strains Used in This Study
| Strain | Genotype | Source | ||
|---|---|---|---|---|
| K699 |
| K. Nasmyth (IMP, Vienna) | ||
| PJ69-4A |
|
| ||
|
| ||||
| SEY6210 |
| S. Emr (University of | ||
| California, San Diego) | ||||
| SEY6211 |
| S. Emr | ||
| SFY526 |
| Clontech | ||
|
| ||||
| Y187 |
| Clontech | ||
| RAY719 | Same as SEY6210 with |
| ||
| RAY899 | Same as SEY6210 with | This study | ||
| RAY910 | Same as SEY6211 with | This study | ||
| RAY912 | Same as SEY6211 with | This study | ||
| RAY931 | Same as SEY6211 with |
| ||
| RAY1034 | Same as SEY6211 with |
| ||
| RAY1035 | Same as SEY6211 with |
| ||
| RAY1036 | Same as PJ69-4A with | This study | ||
| RAY1041 | Same as SEY6210 with |
| ||
| RAY1072 | Same as PJ69-4A with | This study | ||
| RAY1074 | Same as PJ69-4A with | This study | ||
| RAY1086 | Same as PJ69-4A with | This study | ||
| RAY1109 | Same as RAY1034 with | This study | ||
| RAY1111 | Same as RAY1035 with | This study | ||
| RAY1113 | Same as PJ69-4A with | This study | ||
| RAY1114 | Same as PJ69-4A with | This study | ||
| RAY1121 | Same as PJ69-4A with | This study | ||
| RAY1123 | Same as PJ69-4A with | This study | ||
| RAY1135 | Same as SEY6210 except | This study | ||
| RAY1139 | Same as RAY1034 with | This study | ||
| RAY1142 | Same as RAY1035 with | This study | ||
| RAY1160 | Same as RAY1035 with | This study | ||
| RAY1168 | Same as RAY1035 with | This study | ||
| RAY1173 | Same as RAY1034 with | This study | ||
| RAY1179 | Same as PJ69-4A with | This study | ||
| RAY1182 | Same as Y187 with | This study | ||
| RAY1183 | Same as Y187 with | This study | ||
| RAY1246 | Same as RAY1034 with | This study | ||
| RAY1248 | Same as RAY1035 with | This study | ||
| RAY1249 | Same as RAY1034 with | This study | ||
| RAY1254 | Same as K699 with | This study | ||
| RAY1258 | Same as K699 with | This study | ||
| RAY1260 | Same as K699 with | This study | ||
| RAY1271 | Same as RAY1034 with | This study | ||
| RAY1276 | Same as SEY6211 with | This study | ||
| RAY1336 | Same as K699 with | This study | ||
| RAY1342 | Same as RAY1034 with | This study | ||
| RAY1350 | Same as RAY1034 with | This study | ||
| RAY1360 | Same as RAY931 with p414Cdc24HAGFP instead of pEG(KT)CDC24 | This study | ||
| RAY1449 | Same as PJ69-4A with | This study |
HIS5Sp refers to HIS5 from S. pombe and URA3Kl refers to URA3 from K. lactis.
Transformed with LEU2 fragment to make LEU2 +.
Strains made by deletion in a haploid, crossing with appropriate haploid followed by sporulation.
Made by crossing RAY1035 with RAY899 followed by sporulation.
Made by crossing RAY1035 with RAY719 followed by sporulation.
Made by crossing RAY1034 with RAY719 followed by sporulation.
Made by crossing RAY1034 with RAY899 followed by sporulation.
Figure 1Two-hybrid interaction between Cdc24p and Gβ requires Gγ and Far1p. (A) Overexpression of Gγ and Far1p enhances the Cdc24p–Gβ interaction. Assays were carried out in a Y187 strain grown in SC-leu-trp-ade or SC-leu-trp-ade-his. LacZ values are the average of three to five determinations with bars showing standard deviation. As indicated, SPA2 (NH2-terminal 153 amino acids), CDC24, STE4, STE18, or FAR1 (entire ORF) were fused either to GAL4 activation domain (AD) or GAL4 DNA binding domain (DBD). Spa2 serves as a DBDCdc24 negative control and Cdc24-m1 serves as an ADSte4 negative control. For overexpression, NLSHA-STE18 and NLSHA-FAR1 in plasmids p2μATPI and p413TPI were used. (B) Optimal interaction between Cdc24p and Gβ in a diploid requires Gγ and Far1p. Assays were carried out in a diploid strain made by crossing SFY526 and Y187 as described above. (C) Cdc24p–Gβ interaction requires FAR1 orientation function. Assays were carried out in a Y187 strain in which FAR1 was either deleted (RAY1183) or replaced by far1-H7 (RAY1182).
Requirements of Cdc24p Ste4p Interaction
| Strain | Cdc24p Ste4p interaction | +Ste18p | ||
|---|---|---|---|---|
|
| ++ | ND | ||
|
| - | ++ | ||
|
| - | + | ||
|
| - | ± | ||
|
| - | + | ||
|
| - | + | ||
|
| ++ | ND | ||
|
| ++ | ND | ||
|
| - | ± | ||
|
| - | - | ||
|
| ++ | ND | ||
|
| ++ | ND | ||
|
| ++ | ND | ||
|
| ++ | ND |
Two-hybrid assays were carried out in strain PJ69-4A with the indicated gene deletions. Identical results were obtained with at least three transformants. ++ Denotes clear growth on selective plates lacking histidine.
Plates incubated at 25°C.
Far1p Interacts with Cdc24p and Ste4p
| Strain | Far1 Cdc24 interaction | Far1 Ste4 interaction | ||
|---|---|---|---|---|
| Wild-type | ++ | ++ | ||
|
| ++ | ++ | ||
|
| ++ | ++ | ||
|
| ++ | ++ | ||
|
| ++ | ++ | ||
|
| N | ++ |
Two-hybrid assays were carried out in strain PJ69-4A with the indicated gene replacements. Identical results were obtained with at least three transformants. ++ Denotes growth on SC-leu-trp-his or in the case of cdc24-m1 SC-leu-ura-his.
Figure 2Cdc24p specifically binds Far1p in vivo. Extracts from strains (lanes 1 and 2 RAY1254; lanes 3 and 4 RAY1258; lanes 5 and 6 RAY1260; lanes 7 and 8 RAY1336) with an activated pheromone response carrying Far1-protein A (lanes 3–6), Far1-H7-protein A (lanes 7 and 8), 3xmycCdc24 (lanes 1–4 and 7 and 8), and 3xmycCdc24-m1 (lanes 5 and 6) were incubated with IgG-Sepharose and bound proteins analyzed by 10% SDS-PAGE. Upper panel was probed with anti-myc, lower panel with anti-Far1p serum. Bacterially expressed MBPFar1 was added to the sample in lane 1.
Figure 3Cdc24p directly binds Far1p. (A) MBPFar1 (0.3 μM, lanes 3 and 5) or MBPFar1-H7 (0.3 μM, lanes 4 and 6) was incubated the NH2-terminal half of Cdc24 fused to GST denoted GSTCdc24 (1 μM, lanes 3 and 4) or GST (3 μM, lanes 5 and 6) bound to glutathione-agarose. Bound proteins were analyzed by 10% SDS-PAGE, and Coomassie blue staining. Lanes 1 and 2 show standards representing 5% of added MBPFar1 or MBPFar1-H7. Bands at ∼97 kD are breakdown products of MBPFar1 and MBPFar1-H7 that reacted with anti-MBP mAb hence lack the COOH termini. While full-length MBPFar1 was substantially enriched over this MBPFar1 fragment in GSTCdc24 pulldowns, these breakdown products were still observed in resin eluates consistent with MBPFar1 oligomerization. (B) Concentration dependence of MBPFar1 binding to GSTCdc24. MBPFar1-H7 (lanes 3, 4, and 5) and MBPFar1 (lanes 6, 7, and 8) at concentrations 75 nM (lanes 3 and 6), 150 nM (lanes 4 and 7), and 300 nM (lanes 5 and 8) was added to 1 μM GSTCdc24 bound to glutathione-agarose. Samples were analyzed as described above. Lanes 1 and 2 show standards representing 20% (for lanes 3 and 6), 10% (for lanes 4 and 7), and 5% (for lanes 5 and 8) of added MBPFar1 or MBPFar1-H7.
Figure 4Delineation of Far1p region necessary for Cdc24p and Gβ binding. (A) Far1p fragments. Far1 fragments contained amino acid residues 133–831 for Far1, residues 133–756 for Far1-H7, residues 133–297 for Far1ΔC, residues 638–831 for Far1ΔN, and residues 638–756 for Far1-H7ΔN fused to MBP. (B) The Far1p COOH terminus is necessary for Cdc24p binding. GSTCdc24 (0.9 μM) bound to glutathione-agarose was incubated with MBP fusions (∼0.5 μM) as indicated. Samples were analyzed by 10% SDS-PAGE, followed by immunoblotting with anti-MBP mAb and ECL. Lanes 1–6 show standards representing 5% of added MBP fusions and lanes 7–12 show resin eluates. GST alone did not bind any MBP fusions. (C) The NH2 terminus of Far1p is necessary for binding yeast Gβ. Indicated MBP fusions bound to amylose resin were incubated with yeast HASte4p purified from RAY1276. Samples were prepared and analyzed as described above by 10% SDS-PAGE using anti-HA mAb. Anti-MBP immunoblots revealed lanes 4–7 had similar amounts of MBP fusions whereas lanes 2 and 3 had approximately two- to threefold less MBP fusion. Lanes 1 and 8 show standard representing 12.5% and 6.2% of added HASte4p, respectively.
Figure 5Cdc24p, Far1p, and Gβ form a trimeric complex. (A) Cdc24p binds Gβ in the presence of MBPFar1. GSTCdc24 (0.7 μM) bound to glutathione-agarose was incubated with yeast HASte4p and 0.5 μM MBPFar1 or 7.4 μM MBP as indicated. Samples prepared and analyzed by 10% SDS-PAGE as described in Fig. 4 C (α-HA) or analyzed by Coomassie blue staining. For the α-HA blot 10% of added HASte4p was used as a standard. GST alone did not bind HASte4p. (B) A trimeric Cdc24p-Far1p-Gβ complex. GSTCdc24-MBPFar1 was prepared and ∼10% of this complex was analyzed by SDS-PAGE and Coomassie blue staining. Approximately 30% GSTCdc24-MBPFar1 or GSTCdc24 alone was incubated with yeast HASte4p. Samples were prepared and analyzed as described above using anti-HA mAb (α-HA) or anti-MBP mAb (α-MBP). For the α-HA blot 2.5% of added HASte4p was used as a standard.
Figure 6CDC24 and FAR1 function in same shmoo orientation pathway. Quantitative matings were carried out with a wild-type tester (RAY1135) and mating efficiencies (number of diploid cells divided by total number of cells) are the average of three to five determinations with wild-type mating efficiency (42%) set to 100%. Strains RAY1034, RAY1035, RAY1109, RAY1111, RAY1246, RAY1248, RAY1271, RAY1160, RAY1173, and RAY1168 were used. Bars indicate standard deviation.
Figure 7Cdc24p localizes to sites of polarized growth. (A) Cdc24p localizes to sites of polarized growth in budding cells. Confocal micrographs of live Δcdc24 p414Cdc24HAGFP cells (RAY1360) at different stages in the cell cycle. At each stage in the cell cycle background fluorescence was observed in the cytosol that varied from cell to cell. (B) Cdc24p localizes to the shmoo tip. Cells treated with 140 μM α-factor for 1 h were imaged as described above. Bar, 5 μm.
Figure 8Cdc24p localization requires the actin cytoskeleton in shmoos but not budding cells. (A) Cdc24p localization in budding cells does not require the actin cytoskeleton. ΔCdc24 p414Cdc24HAGFP cells (RAY1360) were treated with either 0.1 mM latrunculin A or DMSO for 3 h. Cdc24HAGFP was detected as described in Fig. 7 A. Cells were also fixed and stained with rhodamine phalloidin to visualize actin cytoskeleton. (B) Cdc24p localization in shmoos requires the actin cytoskeleton. RAY1360 cells were treated with 140 μM α-factor for 1 h and then either 0.1 mM latrunculin A or DMSO was added for 2 h. Cdc24HAGFP and actin cytoskeleton were visualized as described above. Note the upper cell in Cdc24 panel treated with DMSO is initiating a second mating projection where Cdc24HAGFP is observed. Fluorescent material within cells in Cdc24 panels is attributed to fluorescence due to ade2. Bar, 5 μm.
Figure 9In the absence of chemotropic signaling BUD1 functions in mating. (A) Combination of Δbud1 with either cdc24-m1 or Δfar1 results in a synthetic mating defect. Quantitative mating carried out as described in Fig. 6. Strains RAY1034, RAY1139, RAY1035, RAY1142, RAY1109, RAY1249, RAY1342, and RAY1350 were used. (B) BUD1 is necessary for shmoo formation in pheromone treated cdc24-m1 cells. DIC images of α-factor treated (12 μM for 3 h) cells (genotype indicated). (C) BUD1 is necessary for shmoo formation in mating mixtures. Cells with genotype indicated stained with Calcofluor white, mated with a wild-type. Fluorescence and DIC images were merged. (D) Actin cytoskeleton is depolarized in cdc24-m1 Δbud1 cells treated with α-factor. Cells with genotype indicated were treated with α-factor and actin cytoskeleton visualized as described in Fig. 7 D. Bars, 5 μm.
Figure 10Model of Cdc24p signaling in growth orientation. Empty rings represent bud scars. Cdc24p is localized to the bud site during vegetative growth and upon exposure to a mating pheromone gradient associates with Far1p and Gβγ that is released by receptor activation (not shown). The dashed line between Cdc24p at the bud site and the site for oriented growth during mating indicates that Cdc24p can switch between these two locations. Presumably Bud1p is involved in signaling to Cdc24p at the bud site. It is assumed that signaling to Cdc24p during mating and budding regulates Cdc42p which is necessary for appropriate orientation of the actin cytoskeleton.